Zhang Ping 4

What Happened
Zhang Ping, a director of Gyre Therapeutics, had a derivative disposition to the issuer on May 14, 2026: a 250,000-share option was canceled. The Form 4 reports the disposition as 250,000 shares at $0.00 (no proceeds). Footnotes state the option was canceled by mutual agreement and that any consideration provided by the issuer will not be economic in value. The canceled option represented a right to purchase 250,000 common shares, with 25% scheduled to vest on May 27, 2026 and the remainder vesting monthly over the following three years, subject to continued service.

Key Details

• Transaction date: 2026-05-14 (reported on Form 4 filed 2026-05-20). Filing appears late relative to the trade date.
• Transaction code: D (Disposition to issuer); reported price: $0.00; total reported proceeds: $0.
• Securities affected: derivative (option) covering 250,000 shares.
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — option canceled by mutual agreement; any issuer consideration will not be economic in value. F2 — option would have covered 250,000 shares with a staggered vesting schedule (25% on 5/27/2026, remainder monthly over 3 years).
• Exhibit included: Exhibit 24 — Power of Attorney.

Context
This was a cancellation of an option (a derivative), not a market sale or purchase of shares, and no cash changed hands per the filing. Cancellation with non-economic consideration does not necessarily indicate insider buying or selling sentiment. Retail investors should treat this as an administrative/contractual change to equity compensation rather than a routine open-market sale or purchase.